Cart
sales@molnova.com
TH-Z145
CAS No. 2260887-57-6
TH-Z145( —— )
Catalog No. M36529 CAS No. 2260887-57-6
TH-Z145 is a potent FPPS inhibitor for the study of myeloma and lung cancer.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 67 | In Stock |
|
| 5MG | 100 | In Stock |
|
| 10MG | 163 | In Stock |
|
| 25MG | 327 | In Stock |
|
| 50MG | 526 | In Stock |
|
| 100MG | 822 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTH-Z145
-
NoteResearch use only, not for human use.
-
Brief DescriptionTH-Z145 is a potent FPPS inhibitor for the study of myeloma and lung cancer.
-
DescriptionTH-Z145, a lipophilic bisphosphonate, is a FPPS inhibitor (IC50: 210 nM).
-
In Vitro——
-
In VivoTH-Z145 (20 μg, i.p.) exhibits strong prophylactic effects in a pathogenic influenza model.Animal Model:B16-OVA cells (s.c.) xenograft mice model.Dosage:20 μg Administration:Intraperitoneal injection (i.p.)Result:Inhibited tumor growth and prolonged survival.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2260887-57-6
-
Formula Weight394.34
-
Molecular FormulaC16H28O7P2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (253.59 mM; Ultrasonic )
-
SMILESC(C(P(=O)(O)O)P(=O)(O)O)C1=CC(OCCCCCCCC)=CC=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Xia Y, et al. The Mevalonate Pathway Is a Druggable Target for Vaccine Adjuvant Discovery. Cell. 2018 Nov 1;175(4):1059-1073.e21. ?
molnova catalog
related products
-
Chikusetsusaponin IV
Chikusetsusaponin IV might relieve cutaneous symptoms caused by excessive apoptotic cell death in the skin through the Fas/FasL pathway.
-
Bromisoval
Bromisoval is a sedative and mild hypnotic with potentially toxic effects.
-
7-hydroxycoumarinyl-...
7-hydroxycoumarinyl-γ-Linolenate is a γ-linolenic acid ester of 7-hydroxycoumarin (umbelliferone) that behaves as a substrate for cPLA2. Hydrolysis of 7-hydroxycoumarinyl-γ-linolenate by phospholipase results in the release of the fluorescent compound 7-hydroxycoumarin which can be monitored spectrophotometrically (excitation at 335 nm, emission at 450 nm).
